FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Graviti Pharmaceuticals Private Atorvastatin Calcium Tablets Recall

Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for:…

Graviti Pharmaceuticals Private Limited · Medak, N/A

Risk level
Class II
Reported by FDA
Feb 12, 2020
Recall ID
D-0832-2020
Check your lot numberHow we source this data

Summary

Graviti Pharmaceuticals Private recalled Atorvastatin Calcium Tablets starting Jan 28, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0832-2020 on Feb 12, 2020. Reason: Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.

Product description

Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA; Manufactured By: Graviti Pharmaceuticals Pvt. Ltd., Telangana -502307, INDIA; NDC 70377-027-11.

Lot numbers, UPCs & expiration codes

Lot #: ATA318099C, Exp 12/2020

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0832-2020
Classification
Class II
Status
Terminated
Recall initiated
Jan 28, 2020
FDA report date
Feb 12, 2020
Quantity
29,056 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Graviti Pharmaceuticals Private Limited

Original FDA data

Every field from FDA enforcement report D-0832-2020, exactly as published.

Show all FDA fields
City
Medak
Status
Terminated
Country
India
Event ID
84814
Address
Survey No. 621 Isnapur Village
Address (line 2)
Patancheru Mandal
Code information
Lot #: ATA318099C, Exp 12/2020
Report date
Feb 12, 2020
Product type
Drugs
Recall number
D-0832-2020
Classification
Class II
Recalling firm
Graviti Pharmaceuticals Private Limited
Product quantity
29,056 bottles
Termination date
Nov 29, 2022
Reason for recall
Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA; Manufactured By: Graviti Pharmaceuticals Pvt. Ltd., Telangana -502307, INDIA; NDC 70377-027-11.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Jan 28, 2020
Initial firm notification
Letter
Center classification date
Feb 7, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0832-2020, published Feb 12, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls